These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 30983921)

  • 1. Erratum to "Prostate Osteoblast-Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients".
    Scimeca M; Urbano N; Bonfiglio R; Mapelli SN; Catapano CV; Carbone GM; Ciuffa S; Tavolozza M; Schillaci O; Mauriello A; Bonanno E
    Contrast Media Mol Imaging; 2019; 2019():7843735. PubMed ID: 30983921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate Osteoblast-Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients.
    Scimeca M; Urbano N; Bonfiglio R; Mapelli SN; Catapano CV; Carbone GM; Ciuffa S; Tavolozza M; Schillaci O; Mauriello A; Bonanno E
    Contrast Media Mol Imaging; 2018; 2018():9840962. PubMed ID: 30627063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erratum: Loss of E-cadherin promotes prostate cancer metastasis via upregulation of metastasis-associated gene 1 expression.
    Fan L; Wang H; Xia X; Rao Y; Ma X; Ma D; Wu P; Chen G
    Oncol Lett; 2020 Apr; 19(4):3359. PubMed ID: 32256830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoblast-like cells in human cancers: new cell type and reliable markers for bone metastasis.
    Scimeca M; Bonfiglio R; Montanaro M; Bonanno E
    Future Oncol; 2018 Jan; 14(1):9-11. PubMed ID: 29219614
    [No Abstract]   [Full Text] [Related]  

  • 5. Erratum: Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling: Erratum.
    Sun X; Li K; Hase M; Zha R; Feng Y; Li BY; Yokota H
    Theranostics; 2023; 13(1):16-19. PubMed ID: 36593961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum for
    Spinal Cord Ser Cases; 2016; 2():16019. PubMed ID: 31265710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current trials using bone-targeting agents in prostate cancer.
    Tu SM; Lin SH
    Cancer J; 2008; 14(1):35-9. PubMed ID: 18303481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum: The metabolic co-regulator PGC1α suppresses prostate cancer metastasis.
    Torrano V; Valcarcel-Jimenez L; Cortazar AR; Liu X; Urosevic J; Castillo-Martin M; Fernández-Ruiz S; Morciano G; Caro-Maldonado A; Guiu M; Zúñiga-García P; Graupera M; Bellmunt A; Pandya P; Lorente M; Martín-Martín N; Sutherland JD; Sanchez-Mosquera P; Bozal-Basterra L; Zabala-Letona A; Arruabarrena-Aristorena A; Berenguer A; Embade N; Ugalde-Olano A; Lacasa-Viscasillas I; Loizaga-Iriarte A; Unda-Urzaiz M; Schultz N; Aransay AM; Sanz-Moreno V; Barrio R; Velasco G; Pinton P; Cordon-Cardo C; Locasale JW; Gomis RR; Carracedo A
    Nat Cell Biol; 2017 Jun; 19(7):873. PubMed ID: 28659639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of the serum levels of bone formation and bone resorption markers in prostate cancer patients with bone metastasis.
    Akimoto S; Inomiya H; Furuya Y; Akakura K; Ito H
    Eur Urol; 1998 Aug; 34(2):142-7. PubMed ID: 9693250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer.
    Lin SC; Lee YC; Yu G; Cheng CJ; Zhou X; Chu K; Murshed M; Le NT; Baseler L; Abe JI; Fujiwara K; deCrombrugghe B; Logothetis CJ; Gallick GE; Yu-Lee LY; Maity SN; Lin SH
    Dev Cell; 2017 Jun; 41(5):467-480.e3. PubMed ID: 28586644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes: Erratum.
    Llop E; Ferrer-Batallé M; Barrabés S; Guerrero PE; Ramírez M; Saldova R; Rudd PM; Aleixandre RN; Comet J; de Llorens R; Peracaula R
    Theranostics; 2018; 8(3):746-748. PubMed ID: 29344303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum.
    J Bras Nefrol; 2019; 41(1):159-161. PubMed ID: 30465594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum.
    Dental Press J Orthod; 2019 Aug; 24(3):113. PubMed ID: 31390445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of osteoblastic bone metastasis of prostate cancer].
    Yonou H; Ogawa Y; Ochiai A
    Clin Calcium; 2006 Apr; 16(4):557- 64. PubMed ID: 16582505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
    Yang J; Fizazi K; Peleg S; Sikes CR; Raymond AK; Jamal N; Hu M; Olive M; Martinez LA; Wood CG; Logothetis CJ; Karsenty G; Navone NM
    Cancer Res; 2001 Jul; 61(14):5652-9. PubMed ID: 11454720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratum: Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism.
    Lodi A; Saha A; Lu X; Wang B; Sentandreu E; Collins M; Kolonin MG; DiGiovanni J; Tiziani S
    NPJ Precis Oncol; 2017; 1(1):30. PubMed ID: 29873330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2.
    Nadiminty N; Lou W; Lee SO; Mehraein-Ghomi F; Kirk JS; Conroy JM; Zhang H; Gao AC
    Clin Cancer Res; 2006 Mar; 12(5):1420-30. PubMed ID: 16533764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPRC5A facilitates cell proliferation through cell cycle regulation and correlates with bone metastasis in prostate cancer.
    Sawada Y; Kikugawa T; Iio H; Sakakibara I; Yoshida S; Ikedo A; Yanagihara Y; Saeki N; Győrffy B; Kishida T; Okubo Y; Nakamura Y; Miyagi Y; Saika T; Imai Y
    Int J Cancer; 2020 Mar; 146(5):1369-1382. PubMed ID: 31276604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine prostate stimulates osteoblast function using the endothelin receptors.
    LeRoy BE; Sellers RS; Rosol TJ
    Prostate; 2004 May; 59(2):148-56. PubMed ID: 15042615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity.
    Nordstrand A; Bovinder Ylitalo E; Thysell E; Jernberg E; Crnalic S; Widmark A; Bergh A; Lerner UH; Wikström P
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.